Trial intelligence / Profile preview

Voriconazole-based Regimen for Peritoneal Dialysis-related Fungal Peritonitis

TCTR20230316005Phase 3Not yet recruiting

Sponsor
Chulalongkorn University
Start
May 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of voriconazole in peritonitis, sponsored by Chulalongkorn University. Planned start May 2023; status: not yet recruiting.

02

Drugs

voriconazole
03

Conditions

peritonitis

Beyond the preview

Go deeper on TCTR20230316005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230316005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call